Structure of the granulocyte macrophage colony-stimulating factor gene in patients with the myelodysplastic syndromes
β Scribed by Jacqueline Boultwood; Gail Abrahamson; Veronica J. Buckle; Katrina Rack; David G. Oscier; James S. Wainscoat
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- English
- Weight
- 207 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
We report a case of a patient who developed a fatal adult respiratory distress syndrome (ARDS) during treatment with rh granulocyte-macrophage colony stimulating factor (rhGM-CSF) (250 mcg/m2/day s.c.) and low-dose cytosine-arabinoside (Ara-C) (20 mg/ m2/day s.c.). Several mechanisms which might exp
## BACKGROUND. The prognosis of patients with high risk myelodysplastic syndromes (MDS) (i.e., refractory anemia with excess of blasts [RAEB] and refractory anemia with excess of blasts in transformation [RAEB-t]) usually is poor. The combination of fludarabine, cytarabine, and granulocyte-colony